Replication of Mini-Sentinel Study Assessing Mirabegron and Cardiovascular Risk in Non-Mini-Sentinel Databases.

Simeone, Jason C; Nordstrom, Beth L; Appenteng, Kwame; Huse, Samuel; D'Silva, Milbhor

Simeone, Jason C; Nordstrom, Beth L; Appenteng, Kwame; Huse, Samuel; D'Silva, Milbhor.

Afiliação

Simeone JC; Real-World Evidence, Evidera, 500 Totten Pond Road, Fifth Floor, Waltham, MA, 02451, USA. jason.simeone@evidera.com.
Nordstrom BL; Real-World Evidence, Evidera, 500 Totten Pond Road, Fifth Floor, Waltham, MA, 02451, USA.
Appenteng K; Safety Science, Astellas Pharma US, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.
Huse S; Real-World Evidence, Evidera, 500 Totten Pond Road, Fifth Floor, Waltham, MA, 02451, USA.
D'Silva M; Safety Science, Astellas Pharma US, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.

Drugs Real World Outcomes ; 5(1): 25-34, 2018 Mar.

Article em En | MEDLINE | ID: mdl-29134621

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google